心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2018 营养和饮食学会循证实践指南：心衰患者的管理

2018-05-11 美国营养与饮食学会 J Acad Nutr Diet. 2018 May 11.

心衰营养治疗

2018年5月，美国营养与饮食学会(Academy of Nutrition and Dietetics)发布了心衰患者的管理，指南针对心衰患者的医学营养治疗提出指导建议,包括医学营养治疗的有效性，医学营养治疗的频率和持续时间，营养评估，能量需求评估，营养干预等。

中文标题：

2018 营养和饮食学会循证实践指南：心衰患者的管理

英文标题：

Academy of Nutrition and Dietetics Evidence-Based Practice Guideline for the Management of Heart Failure in Adults.

发布机构：

美国营养与饮食学会

发布日期：

2018-05-11

简要介绍：

2018年5月，美国营养与饮食学会(Academy of Nutrition and Dietetics)发布了心衰患者的管理，指南针对心衰患者的医学营养治疗提出指导建议,包括医学营养治疗的有效性，医学营养治疗的频率和持续时间，营养评估，能量需求评估，营养干预等。 

拓展指南：与心衰相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 营养和饮食学会循证实践指南：心衰患者的管理)] GetToolGuiderByIdResponse(projectId=1, id=b6d8b1c00159324b, title=2018 营养和饮食学会循证实践指南：心衰患者的管理, enTitle=Academy of Nutrition and Dietetics Evidence-Based Practice Guideline for the Management of Heart Failure in Adults., guiderFrom=J Acad Nutr Diet. 2018 May 11., authorId=null, author=, summary=2018年5月，美国营养与饮食学会(Academy of Nutrition and Dietetics)发布了心衰患者的管理，指南针对心衰患者的医学营养治疗提出指导建议,包括医学营养治疗的有效性，医学营养治疗的频率和持续时间，营养评估，能量需求评估，营养干预等。 , cover=, journalId=null, articlesId=null, associationId=1212, associationName=美国营养与饮食学会, associationIntro=美国营养与饮食学会(Academy of Nutrition and Dietetics), copyright=0, guiderPublishedTime=Fri May 11 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>2018年5月，美国营养与饮食学会(Academy of Nutrition and Dietetics)发布了心衰患者的管理，指南针对心衰患者的医学营养治疗提出指导建议,包括医学营养治疗的有效性，医学营养治疗的频率和持续时间，营养评估，能量需求评估，营养干预等。 </div> <div><br> </div>拓展指南：<strong>与<font color=red>心衰</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=f124c1c001580e21" title="2018 AHA科学声明：右心衰的评估和管理" target=_blank>2018 AHA科学声明：右心衰的评估和管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=a82c61c00156e0c7" title="2018 HFA/ESC立场声明：2型糖尿病和心衰" target=_blank>2018 HFA/ESC立场声明：2型糖尿病和心衰</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=13a191c0015ae861" title="《生物标志物在心衰预防、评估以及管理中的作用》解读" target=_blank>《生物标志物在心衰预防、评估以及管理中的作用》解读</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=f2b191c0015386d2" title="2017 ACC专家共识：优化心衰治疗的决策路径" target=_blank>2017 ACC专家共识：优化心衰治疗的决策路径</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=8896f1c001532287" title="2017 EPCCS实践指南：基层医疗中心衰的诊断和管理" target=_blank>2017 EPCCS实践指南：基层医疗中心衰的诊断和管理</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E5%BF%83%E8%A1%B0" target=_blank>有关心衰更多指南</a></ul>, tagList=[TagDto(tagId=448, tagName=心衰), TagDto(tagId=16972, tagName=营养治疗)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=66, categoryName=营养科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6919, appHits=485, showAppHits=0, pcHits=4828, showPcHits=2635, likes=160, shares=29, comments=6, approvalStatus=1, publishedTime=Fri May 18 23:29:32 CST 2018, publishedTimeString=2018-05-11, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri May 18 23:29:32 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 13:53:29 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 营养和饮食学会循证实践指南：心衰患者的管理)])
2018 营养和饮食学会循证实践指南：心衰患者的管理
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=317373, encodeId=158331e3736d, content=谢谢了.学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Tue May 22 06:12:29 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316806, encodeId=449131680623, content=很好.不错的资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Sun May 20 06:39:54 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316611, encodeId=642b31661166, content=学习了.长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sat May 19 10:48:42 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316536, encodeId=a3e7316536b2, content=好文献学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Sat May 19 07:28:59 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316486, encodeId=7088316486cb, content=学习一下谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat May 19 06:13:42 CST 2018, time=2018-05-19, status=1, ipAttribution=)]
    2018-05-22 txqjm

    谢谢了.学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=317373, encodeId=158331e3736d, content=谢谢了.学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Tue May 22 06:12:29 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316806, encodeId=449131680623, content=很好.不错的资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Sun May 20 06:39:54 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316611, encodeId=642b31661166, content=学习了.长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sat May 19 10:48:42 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316536, encodeId=a3e7316536b2, content=好文献学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Sat May 19 07:28:59 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316486, encodeId=7088316486cb, content=学习一下谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat May 19 06:13:42 CST 2018, time=2018-05-19, status=1, ipAttribution=)]
    2018-05-20 易水河

    很好.不错的资料

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=317373, encodeId=158331e3736d, content=谢谢了.学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Tue May 22 06:12:29 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316806, encodeId=449131680623, content=很好.不错的资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Sun May 20 06:39:54 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316611, encodeId=642b31661166, content=学习了.长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sat May 19 10:48:42 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316536, encodeId=a3e7316536b2, content=好文献学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Sat May 19 07:28:59 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316486, encodeId=7088316486cb, content=学习一下谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat May 19 06:13:42 CST 2018, time=2018-05-19, status=1, ipAttribution=)]
    2018-05-19 1ddf0692m34(暂无匿称)

    学习了.长知识

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=317373, encodeId=158331e3736d, content=谢谢了.学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Tue May 22 06:12:29 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316806, encodeId=449131680623, content=很好.不错的资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Sun May 20 06:39:54 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316611, encodeId=642b31661166, content=学习了.长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sat May 19 10:48:42 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316536, encodeId=a3e7316536b2, content=好文献学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Sat May 19 07:28:59 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316486, encodeId=7088316486cb, content=学习一下谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat May 19 06:13:42 CST 2018, time=2018-05-19, status=1, ipAttribution=)]
    2018-05-19 张新亮1853311252142e2fm

    好文献学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=317373, encodeId=158331e3736d, content=谢谢了.学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Tue May 22 06:12:29 CST 2018, time=2018-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316806, encodeId=449131680623, content=很好.不错的资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Sun May 20 06:39:54 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316611, encodeId=642b31661166, content=学习了.长知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sat May 19 10:48:42 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316536, encodeId=a3e7316536b2, content=好文献学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Sat May 19 07:28:59 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316486, encodeId=7088316486cb, content=学习一下谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat May 19 06:13:42 CST 2018, time=2018-05-19, status=1, ipAttribution=)]
    2018-05-19 三生有幸9135

    学习一下谢谢分享

    0

相关指南

2018 HFA/ESC立场声明：2型糖尿病和心衰

欧洲心力衰竭协会(HFA,Heart Failure Association) · 2018-03-08

《生物标志物在心衰预防、评估以及管理中的作用》解读

暂未更新 · 2017-12-30

2017 EPCCS实践指南：基层医疗中心衰的诊断和管理

欧洲心血管初级保健学会(EPCCS,European Primary Care Cardiovascular Society) · 2017-12-10

2017 AHA科学声明：生物标志物在心衰预防，评估以及管理中的作用

美国心脏协会(AHA,American Heart Association) · 2017-04-26

心力衰竭的春天因你来，最新心力衰竭指南集锦！

暂未更新 · 2017-03-28

2016 ESC意见书：成人先天性心脏病患者心衰的治疗

欧洲心脏病学会(ESC,European Society of Cardiology) · 2016-01-18